Go to contents

THE DONG-A ILBO Logo

Open Menu Close Menu Open Search Bar
검색창 닫기

AI Healthcare

InBody, Mybenefit Launch Unified Body Analysis Platform

Dong-A Ilbo | Updated 2026.07.29
Selected for KRW 6 billion Ministry of Trade, Industry and Energy R&D national project… Combining BIA and 3D AI motion recognition technology
Aiming to deliver next-generation precision healthcare solutions spanning hospitals, fitness, and senior care
 
Global body composition analysis company InBody and AI digital healthcare company MyBenefit are set to develop a next-generation convergence solution that conducts integrated analysis of internal body data and external body shape data.

The two companies announced that they have been finally selected as executing organizations for a national research and development (R&D) project supervised by the Ministry of Trade, Industry and Energy, with a total project budget of approximately KRW 6.0 billion, and have signed an agreement to begin full-scale technology development.

The core of this project is to build a precision healthcare platform that organically measures and analyzes internal body composition information and external postural alignment within a single measurement device and integrated analysis software environment. The focus is on improving the existing approach, in which each element was measured in a fragmented manner using separate devices, and on enhancing user convenience.

To this end, InBody’s bioelectrical impedance analysis (BIA)-based body composition measurement technology and MyBenefit’s 3D motion recognition AI body-shape analysis technology will be utilized. The two companies plan to go beyond simply combining the two functions physically and to build an integrated data model that analyzes the correlations between internal body components and external skeletal structure from multiple perspectives.

In addition, while promoting the development of single integrated measurement hardware and dedicated software, the companies plan to sequentially carry out medical device approvals and quality certification procedures in accordance with relevant regulations in line with future commercialization stages.

If development is successfully completed, the platform is expected to be able to expand its applications to a wide range of fields, including medical institutions and health check-up centers, employee assistance programs (EAP) for corporate staff health management, fitness and wellness, and senior care.

A representative of the two companies stated, “By creating synergies between domestic body composition and body-shape measurement technologies, we will strengthen technological competitiveness in the digital healthcare sector and, following rigorous verification, introduce a highly sophisticated commercialization model.”

Choi Yong-seok

AI-translated with ChatGPT. Provided as is; original Korean text prevails.
Popular News